Stock CHE CHEMED CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Chemed Corporation

Equities

CHE

US16359R1032

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-24 pm EDT 		5-day change 1st Jan Change
618 USD +0.23% Intraday chart for Chemed Corporation +1.31% +5.68%
Apr. 24 Chemed Q1 Adjusted Earnings, Revenue Rise -- Shares Down After Hours MT
Apr. 24 Earnings Flash (CHE) CHEMED CORPORATION Reports Q1 Revenue $589.2M, vs. Street Est of $591.1M MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Chemed Q1 Adjusted Earnings, Revenue Rise -- Shares Down After Hours
MT
Chemed: Q1 Earnings Snapshot
AQ
Earnings Flash (CHE) CHEMED CORPORATION Reports Q1 Revenue $589.2M, vs. Street Est of $591.1M
MT
Earnings Flash (CHE) CHEMED CORPORATION Reports Q1 EPS $5.20, vs. Street Est of $5.48
MT
Chemed Reports First-Quarter 2024 Results
BU
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
BU
Chemed Corporation Receives Shareholders Proposal from John Chevedden
CI
Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25
BU
Chemed Insider Sold Shares Worth $1,283,300, According to a Recent SEC Filing
MT
Chemed Insider Sold Shares Worth $1,704,321, According to a Recent SEC Filing
MT
Chemed Insider Sold Shares Worth $7,196,910, According to a Recent SEC Filing
MT
Chemed Corporation - VITAS to Buy Hospice Assets of Covenant Care in Florida and Alabama
AQ
VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama
BU
Transcript : Chemed Corporation Presents at Oppenheimer 34th Annual Healthcare MedTech & Services Conference 2024, Mar-12-2024 12:00 PM
Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference
AQ
Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference
BU
RBC Boosts Price Target on Chemed to $712 From $604, Expects 'Strong' VITAS Momentum to Continue in 2024; Outperform Kept
MT
Oppenheimer Raises Chemed Price Target to $650 From $625, Maintains Outperform Rating
MT
Transcript : Chemed Corporation, Q4 2023 Earnings Call, Feb 28, 2024
Chemed: Q4 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CHE Stock
  4. News Chemed Corporation